Literature DB >> 3798457

D-penicillamine induces rat hepatic metallothionein.

H E Heilmaier, J L Jiang, H Greim, P Schramel, K H Summer.   

Abstract

Intraperitoneal injection of D-Penicillamine (D-PA) at a dose range of 20-500 mg/kg increased rat hepatic but not renal and pancreatic metallothionein (MT). Elevated MT predominantly contained Zn. Maximal induction was obtained 18 h after a single injection of 200 mg D-PA/kg resulting in 148 +/- 18 micrograms MT/g liver which was 16.4-times the control level of 9 +/- 2 micrograms MT/g. At 48 h after injection, MT declined to 18 +/- 9 micrograms MT/g liver. At maximal MT increase the content of total hepatic Zn but not of Cu was elevated. Increased amounts of Zn in liver homogenate, cytosol and MT could be detected approximately 4 h after injection of 200 mg D-PA/kg. Concomitantly there was a decrease in Zn bound to cytosolic non-MT ligands. All Zn changes reversed at 18 h. These data show that already single doses of D-PA cause induction of Zn-thionein in rat liver and lead to synchronous redistribution of Zn from endogenous sources to newly synthesized MT.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3798457     DOI: 10.1016/0300-483x(86)90089-2

Source DB:  PubMed          Journal:  Toxicology        ISSN: 0300-483X            Impact factor:   4.221


  3 in total

1.  Wilson's disease with severe hepatic insufficiency: beneficial effects of early administration of D-penicillamine.

Authors:  F Durand; J Bernuau; E Giostra; G Mentha; D Shouval; C Degott; J P Benhamou; D Valla
Journal:  Gut       Date:  2001-06       Impact factor: 23.059

2.  Metallothionein induction by nonsteroidal antiinflammatory drugs.

Authors:  K H Summer; D Klein; N de Ruiter; J Abel
Journal:  Biol Trace Elem Res       Date:  1989 Jul-Sep       Impact factor: 3.738

3.  The effect of zinc and D-penicillamine in a stable human hepatoma ATP7B knockout cell line.

Authors:  Gursimran Chandhok; Nadine Schmitt; Vanessa Sauer; Annu Aggarwal; Mohit Bhatt; Hartmut H J Schmidt
Journal:  PLoS One       Date:  2014-06-03       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.